CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program under the Inflation Reduction Act (IRA). Teva claims ...

The results of the first round of IRA negotiations, announced in August, saw the list prices of 10 high-cost drugs get slashed ... given that KFF polling has found that over a quarter of Americans ...

The IRA's second phase targets price negotiations for 15 medications, including semaglutide, to reduce costs for Medicare patients. Price negotiations, effective in 2027, cover drugs for diabetes ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Signed into law by Biden in August 2022, the IRA included the Empowering Medicare Seniors to Negotiate Drug Prices Act, a bill sponsored by Sen. Amy Klobuchar, D-Minnesota, which ended the ban on ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations ... correct what they see as the biggest flaw in the IRA - the shorter window time for small molecule drugs ...

The fact that Medicare spends so much on 25 drugs — out of the roughly 8,000 medications it covers — shows the importance of being able to negotiate better prices ... Policy at KFF, a ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and ... the Inflation Reduction Act (IRA), which passed Congress in ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations ...